Skip to main navigation
  • About Us
    • Mission
    • Executive Officers
    • Board of Directors
    • In the Community
    • Contact Us
  • Our ADC Technology
    • What is an ADC?
    • ADC Design
    • With Checkpoint Inhibitors
    • Our Partners
    • Kadcyla
  • Pipeline
    • Mirvetuximab Soravtansine
    • Coltuximab Ravtansine
    • IMGN529
    • IMGN779
    • IMGN632
    • Cancer Trials
    • Partner Compounds
    • Publications
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Executive Officers
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Key Ratios
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
      • Ownership Profile
    • Contact Us
  • Careers
    • Benefits
ImmunoGen, Inc.
  • About Us
    • Mission
    • Executive Officers
    • Board of Directors
    • In the Community
    • Contact Us
  • Our ADC Technology
    • What is an ADC?
    • ADC Design
    • With Checkpoint Inhibitors
    • Our Partners
    • Kadcyla
  • Pipeline
    • Mirvetuximab Soravtansine
    • Coltuximab Ravtansine
    • IMGN529
    • IMGN779
    • IMGN632
    • Cancer Trials
    • Partner Compounds
    • Publications
  • Investors

    Investor

    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Contact Us
  • Careers
    • Benefits
  • Contact Us
  • 10-Q/A

    SEC Filing Details

    Document Details

    Form
    10-Q/A
    Filing Date
    Oct 10, 2012
    Document Date
    Mar 31, 2012
    Form Description
    Amendment to a previously filed 10-Q
    Filing Group
    Quarterly Filings
    Company
    ImmunoGen, Inc.
    Issuer
    IMMUNOGEN INC

    Filing Formats

    View HTML
    Download PDF
    Download DOC
    Download XLS

      Shareholder Tools

      • Email Alerts
      • Print
      • Share

      • Facebook
      • Google
      • LinkedIn
      • Twitter
      • RSS

    Investor Relations

    • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Contact Us
    © 2018 ImmunoGen, Inc.. Sitemap | Privacy Policy | Usage Policy